Sun Pharma to Buy India’s Ranbaxy for $4B

Sun Pharma to Buy India’s Ranbaxy for $4B Play

April 7 (Bloomberg) –- Bloomberg’s John Dawson reports on India’s largest drug maker agreeing to purchase Ranbaxy in a $4B stock transaction. He speaks to Rishaad Salamat on Bloomberg Television’s “On The Move Asia.” (Source: Bloomberg)

  • On Air Now

    Political Capital with Al Hunt Watch Now

  • Next

    Studio 1.0: Reid Hoffman

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus